AC
STAB

Armistice Capital’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Armistice Capital’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-320,053
Closed -$1.1M – 143
2020
Q4 		$1.1M Buy
+320,053
New +$911K 0.04% 98

Other funds holding STAB

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Armistice Capital's STAB Position: Q1 2021 in Review

Armistice Capital sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2021, closing a stake of 320,053 shares — an estimated $1.1M sold.

Armistice Capital first reported a position in STAB in Q4 2020 and held it in 1 quarter. The position peaked at $1.1M in Q4 2020. 22 funds tracked by Wall St. Rank hold STAB as of Q1 2021.

  • Armistice Capital reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Armistice Capital sold 320,053 Statera Biopharma, Inc. Common Stock shares in Q1 2021, an estimated $1.1M.
  • Armistice Capital first reported a position in Statera Biopharma, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Armistice Capital's Statera Biopharma, Inc. Common Stock position peaked at $1.1M in Q4 2020.
  • 22 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2021.

Based on Armistice Capital's 13F filing for Q1 2021, filed 17 May 2021.